13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Miltefosine is the first oral drug with demonstrable success in treating visceral leishmaniasis in adults. Because approximately one-half of the visceral leishmaniasis patients worldwide are children, we performed a Phase I/II dose ranging study in the pediatric population in India.

          Related collections

          Author and article information

          Journal
          Pediatr Infect Dis J
          The Pediatric infectious disease journal
          Ovid Technologies (Wolters Kluwer Health)
          0891-3668
          0891-3668
          May 2003
          : 22
          : 5
          Affiliations
          [1 ] Institutes of Medical Sciences, Banaras Hindu University, 6 SK Gupta Nagar, Varanasi 221005, India. Shyams@sancharnet.in
          Article
          10.1097/01.inf.0000066877.72624.cb
          12792385
          58c645d7-e3fc-406e-b787-0caeead5d6fa
          History

          Comments

          Comment on this article